Astellas Pharma US Revenue and Competitors
Estimated Revenue & Valuation
- Astellas Pharma US's estimated annual revenue is currently $46.6M per year.
- Astellas Pharma US's estimated revenue per employee is $261,978
Employee Data
- Astellas Pharma US has 178 Employees.
- Astellas Pharma US grew their employee count by -4% last year.
Astellas Pharma US's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Technology Architect/ Programme Delivery Lead- Global Commercial Data and Analytics | Reveal Email/Phone |
2 | National VP Sales | Reveal Email/Phone |
3 | Head Global Commercial Strategy, Planning and Transformation | Reveal Email/Phone |
4 | SVP, Head Medical & Development Strategy & Operations, Astellas Pharma | Reveal Email/Phone |
5 | SVP Commercial Strategy | Reveal Email/Phone |
6 | VP Global Brand Lead - XTANDI | Reveal Email/Phone |
7 | Head Commercial Alliances | Reveal Email/Phone |
8 | Head Global Market Access Excellence and Capabilities | Reveal Email/Phone |
9 | VP and Head Oncology MA-US. Medical and Development. Astellas Pharma Inc. | Reveal Email/Phone |
10 | Head Ethics & Compliance BeLux and Ireland | Reveal Email/Phone |
Astellas Pharma US Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13.1M | 65 | 30% | N/A | N/A |
#2 | $75.6M | 376 | 7% | N/A | N/A |
#3 | $23.9M | 119 | 13% | $35M | N/A |
#4 | $12.7M | 63 | -3% | N/A | N/A |
#5 | $5.4M | 27 | -25% | N/A | N/A |
#6 | $6M | 30 | -35% | N/A | N/A |
#7 | $6.6M | 33 | -8% | N/A | N/A |
#8 | $13.5M | 67 | -3% | N/A | N/A |
#9 | $186.3M | 927 | 19% | N/A | N/A |
#10 | $4.4M | 22 | -4% | N/A | N/A |
What Is Astellas Pharma US?
Astellas Pharma US, Inc., a US subsidiary of Tokyo-based Astellas Pharma Inc., is a research-based pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. Established on April 1, 2005, Astellas Pharma Inc. was formed through a merger that combined the outstanding research, development and marketing capabilities of Fujisawa Pharmaceutical Co., Ltd. and Yamanouchi Pharmaceutical Co., Ltd. Astellas ranks among the top 20 pharmaceutical companies in the world and will continue to grow as a competitive company in the world pharmaceutical market. For more information on Astellas Pharma US, Inc.,
keywords:N/A
N/A
Total Funding
178
Number of Employees
$46.6M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Astellas Pharma US News
GlaxoSmithKline Plc., Astellas Pharma Synergy Pharmaceuticals Bayer AG, Allergan Plc., Ironwood Pharmaceuticals Sanofi S.A., Pfizer, Inc.
Astellas Pharma; Inc. (japan); Pfizer; Inc. (us); Teva Pharmaceutical Industries Limited (israel); Allergan; Plc (ireland)...
Other Companies in Northbrook
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $28.7M | 180 | 33% | N/A |
#2 | N/A | 182 | 58% | N/A |
#3 | $47.2M | 189 | 9% | N/A |
#4 | $48.2M | 193 | -15% | N/A |
#5 | $60M | 202 | 16% | N/A |